Eradication of Helicobacter pylori Infection in Patients with Non-Ulcer Dyspepsia: Effects on Basal and Bombesin-Stimulated Serum Gastrin and Gastric Acid Secretion

References

• Graham DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991; 6: 105–13
   PubMed Web of Science ®Google Scholar
• Nomura A, Stemmermann G N, Chyou P H, Kato I, Perez-Perez G I, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132–6
   PubMed Web of Science ®Google Scholar
• Rauws F A, Langenberg W, Houthoff H J, Zanen H C, Tytgat GN. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33–40
   PubMed Web of Science ®Google Scholar
• Loffeld R J, Potters H V, Stobberingh E, Flendrig J A, van-Spreeuwel J P, Arends JW. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 1989; 30: 1206–12
   PubMed Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R, Murray R, Blincow E D, Blackbourn S J, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
   PubMed Web of Science ®Google Scholar
• Levi S, Beardshall K, Haddad G, Playford R J, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastric link. Lancet 1989; 1: 1167–8
   PubMed Web of Science ®Google Scholar
• Graham D Y, Opekun A, Lew G M, Klein P D, Walsh JH. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology 1991; 100: 1571–5
   PubMed Web of Science ®Google Scholar
• Mulholland G, Ardill J E, Fillmore D, Chittajallu R S, Fullarton G M, McColl KE. Helicobacter pylon related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut 1993; 34: 757–61
   PubMed Web of Science ®Google Scholar
• Gregory R A, Tracy HJ. The constitution and properties of two gastrins extracted from dog antral mucosa. Gut 1964; 5: 103–17
   PubMed Web of Science ®Google Scholar
• Moss S F, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993; 34: 888–92
   PubMed Web of Science ®Google Scholar
• Montbriand J R, Appelman H D, Cotner E K, Nostrant T T, Elta GH. Treatment of Campylobacter pylori does not alter gastric acid secretion. Am J Gastroenterol 1989; 84: 1513–6
   PubMed Web of Science ®Google Scholar
• El-Omar E, Penman I, Dorrian C A, Ardill J E, McColl KE. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993; 34: 1060–5
   PubMed Web of Science ®Google Scholar
• Mc Coll K E, Fullarton G M, Chittajalu R, El-Nujumi A M, Mac Donald A M, Dahill S W, et al. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 26: 339–46
   PubMed Web of Science ®Google Scholar
• Smith J T, Pounder R E, Nwokolo C U, Lanzon-Miller S, Evans D G, Graham D Y, et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990; 31: 522–5
   PubMed Web of Science ®Google Scholar
• Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992; 102: 720–7
   PubMed Web of Science ®Google Scholar
• Isenberg J I, Grossman M I, Maxwell V, Walsh JH. Increased sensitivity to stimulation of acid secretion by pentagastrin in duodenal ulcer. J Clin Invest 1975; 55: 330–7
   PubMed Web of Science ®Google Scholar
• Petersen H, Myren J. Pentagastrin dose-response in peptic ulcer disease. Sand J Gastroenterol 1975; 10: 705–14
   PubMed Web of Science ®Google Scholar
• Chittajallu R S, Howie C A, McColl KE. Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects. Scand J Gastroenterol 1992; 27: 857–862
   PubMed Web of Science ®Google Scholar
• Beardshall K, Moss S, Gill J, Levi S, Ghosh P, Playford R J, et al. Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients. Gut 1992; 33: 601–3
   PubMed Web of Science ®Google Scholar
• Brady C E, Hadfield T L, Hyatt J R, Utts SJ. Acid secretion and serum gastrin levels in individuals with Campylobacter pylori. Gastroenterology 1988; 94: 923–7
   PubMed Web of Science ®Google Scholar
• Kuipers E T, Bloemema E, Hazenberg H JA, Lindeman J, Klinkenberg-Knol E C, Meuwissen S GM. Changes in Helicobacter pylori associated gastritis during acid suppressive therapy. Gastroenterology 1994; 106: a112
   Web of Science ®Google Scholar
• Jansen J B, Lamers CB. Effect of bombesin on plasma cholecystokinin in normal persons and gastrectomized patients measured by sequence-specific radioimmunoassays. Surgery 1984; 96: 55–60
   PubMed Web of Science ®Google Scholar
• Jansen J B, Lundborg P, Baak L C, Greve J, Ohman M, Stover C, et al. Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man. Gut 1988; 29: 75–80
   PubMed Web of Science ®Google Scholar
• Jansen J B, Lamers CB. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with the Zollinger-Ellison syndrome. Gastroenterology 1982; 83: 173–8
   PubMed Web of Science ®Google Scholar
• Vergin H, Krammer R, Nitsche V, Miczka M, Strobel K, Schimmel H. Bioavailability and pharmacokinetics of rectally administered metoclopramide. Arzneimittelforschung 1990; 40: 679–83
   PubMed Web of Science ®Google Scholar
• Peterson W L, Barnett C C, Evans D JJ, Feldman M, Carmody T, Richardson C, et al. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol 1993; 88: 2038–43
   PubMed Web of Science ®Google Scholar
• Graham D Y, Alpert L C, Smith J L, Yoshimura HH. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988; 83: 974–80
   PubMed Web of Science ®Google Scholar
• Goldschmiedt M, Barnett C C, Schwarz B E, Kames W E, Redfern J S, Feldman M. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991; 101: 977–90
   PubMed Web of Science ®Google Scholar
• Cave D R, Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989; 2: 187–9
   PubMed Web of Science ®Google Scholar
• Queiroz D M, Mendes E N, Rocha G A, Cunha-Melo J R, Barbosa A J, Lima G FJ, et al. Helicobacter pylori and gastric histamine concentrations. J Clin Pathol 1991; 44: 612–3
   PubMed Web of Science ®Google Scholar
• Moore J G, Wolfe M. The relation of plasma gastrin to the circadian rhythm of gastric acid secretion in man. Digestion 1973; 9: 97–105
   PubMed Web of Science ®Google Scholar
• Gedde-Dahl D. Radioimmunoassay of gastrin. Fasting serum levels in humans with normal and high gastric acid secretion. Scand J Gastroenterol 1974; 9: 41–7
   PubMed Web of Science ®Google Scholar
• Trudeau W L, McGuigan JE. Relations between serum gastrin levels and rates of gastric hydrochloric acid secretion. N Engl J Med 1971; 284: 408–12
   PubMed Web of Science ®Google Scholar
• Hirschowitz B I, Danilewitz M, Molina E. Inhibition of basal acid, cloride, and pepsin secretion in duodenal ulcer by graded doses of ranitidine and atropine with studies of pharmacokinetics of ranitidine. Gastroenterology 1982; 82: 1314–26
   PubMed Web of Science ®Google Scholar
• Achord JL. Gastric pepsin and acid secretion in patients with acute and healed duodenal ulcer. Gastroenterology 1981; 81: 15–8
   PubMed Web of Science ®Google Scholar